Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2014-06-19 AGM Information
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
2013年年度股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the 2013 Annual General Meeting (AGM) of the company, dated June 30, 2014. It includes the agenda for the AGM, which covers the review and approval of the 2013 Annual Report, the 2013 Board of Directors work report, the 2013 Supervisory Board work report, the 2013 financial statements, profit distribution plan, and the proposal to reappoint the auditing firm for 2014. The document contains detailed reports and financial data, including management discussion and analysis, financial results, and audit information. It is clearly the full set of materials presented at the AGM, including the full annual report and related reports, not just an announcement or summary. Therefore, this document fits the category of AGM Information (AGM-R), as it is the presentation and materials shared during the Annual General Meeting, rather than the standalone annual report (10-K) or audit report (AR). The length and content confirm it is a comprehensive AGM document.
2014-06-19 Chinese
关于收购协和干细胞基因工程有限公司33%股权的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of an acquisition of a 33% equity stake in a company. It details the transaction terms, contract signing, payment schedules, and related contractual obligations. There is no indication that this is a full annual or interim report, audit report, or earnings release. It is a specific update on a capital transaction involving equity acquisition. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is short and focused on the acquisition progress, not a report publication or regulatory filing. Confidence is high due to clear transaction details and terminology.
2014-06-10 Chinese
2014年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2014 third extraordinary general meeting of shareholders of the company. It includes information about the meeting date, attendance, voting results on various proposals, and legal opinions on the meeting's validity. The content focuses on shareholder voting outcomes and meeting procedures rather than financial results or management commentary. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 3411 characters, which is consistent with a detailed voting results announcement rather than a brief report publication or a full report. Therefore, the appropriate classification is DVA.
2014-06-09 Chinese
2014年第三次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the legality and procedures of a company's 2014 third extraordinary shareholders' meeting. It details the convening, attendance, voting procedures, and results of the meeting. The content focuses on the validation of the shareholders' meeting process and resolutions, not on the meeting materials themselves or the announcement of voting results. The document is not a report of voting results alone but a legal opinion on the meeting's conduct and resolutions. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to official validation and announcement of shareholder meeting voting outcomes and procedures.
2014-06-09 Chinese
2014年第二次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the procedures, qualifications, and results of a company's 2014 second extraordinary shareholders' meeting. It details the convening, attendance, voting procedures, and confirms the legality and validity of the meeting and resolutions passed. It is not a financial report, earnings release, or management discussion. It is a legal opinion related to a shareholders' meeting, specifically about voting and meeting procedures and results. This fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports on the official voting results and validates the meeting's resolutions.
2014-06-06 Chinese
2013年年度股东大会会议通知
AGM Information Classification · 95% confidence The document is a notice for the 2013 Annual General Meeting (AGM) of Zhongyuan Xiehe Stem Cell Bioengineering Co., Ltd., detailing the date, location, agenda items including the 2013 annual report, board and supervisory reports, financial statements, profit distribution plan, and auditor appointment. It includes procedural information for shareholders to attend and vote, as well as an attached proxy authorization form. The document does not contain the actual annual report or financial statements but is a formal meeting notification and agenda. Therefore, it fits the category of AGM Information (AGM-R). The document length is 2558 characters, which is consistent with a meeting notice rather than a full report.
2014-06-06 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.